These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 12434391

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
    Niederwanger V, Gozzo F, Griesser UJ.
    J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
    [Abstract] [Full Text] [Related]

  • 23. Raman detected differential scanning calorimetry of polymorphic transformations in acetaminophen.
    Kauffman JF, Batykefer LM, Tuschel DD.
    J Pharm Biomed Anal; 2008 Dec 15; 48(5):1310-5. PubMed ID: 18930622
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Investigations on the polymorphism and pseudopolymorphism of triamcinolone diacetate.
    Suitchmezian V, Jess I, Näther C.
    Int J Pharm; 2006 Oct 12; 323(1-2):101-9. PubMed ID: 16828995
    [Abstract] [Full Text] [Related]

  • 27. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
    Qi S, Avalle P, Saklatvala R, Craig DQ.
    Eur J Pharm Biopharm; 2008 May 12; 69(1):364-71. PubMed ID: 18036792
    [Abstract] [Full Text] [Related]

  • 28. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E, Curzi M, Giaffreda SL, Grepioni F, Maini L, Braga D.
    J Pharm Pharmacol; 2015 Jun 12; 67(6):823-9. PubMed ID: 25644936
    [Abstract] [Full Text] [Related]

  • 29. Solid-state characterization of chlordiazepoxide polymorphs.
    Singh D, Marshall PV, Shields L, York P.
    J Pharm Sci; 1998 May 12; 87(5):655-62. PubMed ID: 9572919
    [Abstract] [Full Text] [Related]

  • 30. Characterization of two polymorphs of lornoxicam.
    Zhang J, Tan X, Gao J, Fan W, Gao Y, Qian S.
    J Pharm Pharmacol; 2013 Jan 12; 65(1):44-52. PubMed ID: 23215687
    [Abstract] [Full Text] [Related]

  • 31. Solubility behavior of lamivudine crystal forms in recrystallization solvents.
    Jozwiakowski MJ, Nguyen NA, Sisco JM, Spancake CW.
    J Pharm Sci; 1996 Feb 12; 85(2):193-9. PubMed ID: 8683448
    [Abstract] [Full Text] [Related]

  • 32. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov 12; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 33. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G, Berbenni V, Milanese C, Girella A, Cardini A, Viganò E, Lanfranconi S, Marini A.
    J Pharm Biomed Anal; 2009 Dec 05; 50(5):764-70. PubMed ID: 19570642
    [Abstract] [Full Text] [Related]

  • 34. Characterization of pharmaceutical polymorphs by isothermal calorimetry.
    Urakami K.
    Curr Pharm Biotechnol; 2005 Jun 05; 6(3):193-203. PubMed ID: 15974974
    [Abstract] [Full Text] [Related]

  • 35. Comprehensive spectroscopic characterization of finasteride polymorphic forms. Does the form X exist?
    Frelek J, Górecki M, Dziedzic A, Jabłońska E, Kamieński B, Wojcieszczyk RK, Luboradzki R, Szczepek WJ.
    J Pharm Sci; 2015 May 05; 104(5):1650-7. PubMed ID: 25648836
    [Abstract] [Full Text] [Related]

  • 36. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
    Kimura K, Hirayama F, Uekama K.
    J Pharm Sci; 1999 Apr 05; 88(4):385-91. PubMed ID: 10187747
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of reversible polymorphic phase transitions by thermal analysis.
    Shah AC, Britten NJ.
    J Pharm Pharmacol; 1987 Sep 05; 39(9):736-8. PubMed ID: 2890741
    [Abstract] [Full Text] [Related]

  • 38. Characterization of temperature-induced phase transitions in five polymorphic forms of sulfathiazole by terahertz pulsed spectroscopy and differential scanning calorimetry.
    Zeitler JA, Newnham DA, Taday PF, Threlfall TL, Lancaster RW, Berg RW, Strachan CJ, Pepper M, Gordon KC, Rades T.
    J Pharm Sci; 2006 Nov 05; 95(11):2486-98. PubMed ID: 16892211
    [Abstract] [Full Text] [Related]

  • 39. Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and II on the dissolution properties of drug products.
    Bonfilio R, Leal JS, Santos OM, Pereira GR, Doriguetto AC, de Araújo MB.
    J Pharm Biomed Anal; 2014 Jan 05; 88():562-70. PubMed ID: 24216278
    [Abstract] [Full Text] [Related]

  • 40. Devitrification of amorphous celecoxib.
    Gupta P, Bansal AK.
    AAPS PharmSciTech; 2005 Sep 30; 6(2):E223-30. PubMed ID: 16353981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.